Related Experiment Videos
Recent developments in the maytansinoid antitumor agents.
John M Cassady1, Kenneth K Chan, Heinz G Floss
1College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, USA.
Chemical & Pharmaceutical Bulletin
|January 8, 2004
Summary
Maytansinoids, potent antitumor compounds, show promise when conjugated to antibodies for targeted cancer therapy. Recent research explores their biosynthesis, metabolism, and ecological origins.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Molecular Biology
Background:
- Maytansine and related maytansinoids are highly potent natural products with antitumor activity.
- Previous clinical trials with maytansine were disappointing.
- The last two decades have seen significant advancements in maytansinoid research.
Purpose of the Study:
- To review recent developments in maytansinoid chemistry and biology.
- To highlight novel applications of maytansinoids in cancer therapy.
- To discuss biosynthesis, metabolism, and ecological aspects of maytansinoids.
Main Methods:
- Review of recent scientific literature (last two decades).
- Analysis of maytansinoid applications in antibody-drug conjugates.
- Examination of studies on maytansinoid biosynthesis and metabolism.
Main Results:
- Maytansinoids are effectively utilized as "warheads" in antibody-drug conjugates for targeted cancer treatment.
- Preliminary studies on maytansinoid metabolism have been conducted.
- Investigations into the biochemical and genetic pathways of maytansinoid biosynthesis are ongoing.
- Ecological factors influencing the presence of maytansinoids in plants are being explored.
Conclusions:
- Maytansinoids remain critical compounds in the development of targeted cancer therapies.
- Further research into biosynthesis, metabolism, and ecological roles is essential.
- The review synthesizes recent progress, guiding future investigations in the field.